What is CAGR? What does CAGR table indicate for Venkat Pharma Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Venkat Pharma Ltd Stock Analysis

Q: Is Venkat Pharma Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Venkat Pharma Ltd and arrived at the following conclusion.

Q: Is the current market price of Venkat Pharma Ltd a good price to buy it?

The 5-year analysis of Venkat Pharma Ltd's performance infers.

Q: What is Venkat Pharma Ltd share price return in the past 10 years?

We analysed the performance of Venkat Pharma Ltd share prices over the last 10 years. Here is what we found out:

Small Cap

Evaluated by 45 users | BSE: 532093 | NSE: |
Pharmaceuticals & Drugs

Venkat Pharma Ltd is a public limited company registered under the Indian Companies Act 1956 and their stock is listed in Bombay Stock Exchange (BSE) and is being actively traded. Established in 1989 it started manufacturing & sales of pharma products in 1992. The company is solely into...

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Return on Capital Employed	3.95%	1.32%	5.92%	0	4.89%	7.16%	-1.54%	-0.46%	-0.24%	-0.26%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	19.7	41.7	51.9	0	47.8	36.4	0	0	0	0
Y-o-Y Gr. Rt.	-	111.5%	24.5%	-100%	NA	-23.9%	-100%	NA	NA	NA
Adjusted EPS (Rs.)	0.16	0.08	0.94	0	0.42	0.48	-0.51	-0.13	-0.07	-0.09
Y-o-Y Gr. Rt.	-	-50%	1075%	-100%	NA	14.3%	-206.3%	NA	NA	NA
Book Value per Share (Rs.)	10.7	10.81	11.81	0	14.58	15.09	-4.8	-4.93	-5	-5.09
Adjusted Net Profit	0.1	0	0.3	0	0.2	0.2	-0.3	-0.1	0	0
Net Op. Cash Flow (Rs. Cr.)	0.9	-0.8	0.3	0	-1.5	0.3	0	0	0	0
Debt to Cash Flow from Ops	2.74	-2.67	6.51	0	-4.71	43.94	-6,228.47	-12,456.95	-1,536.16	-14,785.43

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Venkat Pharma Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Venkat Pharma Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	-100%	-100%	NA	NA
Adjusted EPS	-193.8%	-173.5%	NA	NA
Book Value per Share	-192.1	-181	0	0
Share Price	-	-	-	-

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Return on Equity (%)	1.4	0.71	8.03	0	3.49	3.22	-11.23	2.65	1.48	1.76
Operating Profit Margin (%)	2.69	0.69	1.15	0	1.95	5.3	0	0	0	0
Net Profit Margin (%)	0.28	0.07	0.63	0	0.4	0.6	0	0	0	0
Debt to Equity	0.67	0.55	0.47	0	1.08	1.78	-6.76	-6.59	-7.7	-7.57
Working Capital Days	0	251	206	0	189	240	0	0	0	0
Cash Conversion Cycle	0	46	46	0	80	162	0	0	0	0

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	22.35%
Non-Institutions	77.65%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Venkat Pharma Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Venkat Pharma Ltd a good price to buy it?

Data is not available for this company.

3. What is Venkat Pharma Ltd share price return in the past 10 years ?

Data is not available for this company

About Company

At Venkat Pharma they meticulously manufacture pharma products, and constantly improvise

At Venkat Pharma they meticulously manufacture pharma products, and constantly improvise existing product mix, thereby carving out a niche for themselves, in the global playing field of pharma.

Their philosophy is to provide value priced and quality pharmaceutical products to the humankind at large. At Venkat, they believe, that there is no compromise on the health of a human being. Their growth rate is quite above the industry CAGR growth rates as they are growing at a rate of 35% year on year.

Product range of the company includes:

API
PFIs
Finished Dosage
Under Development
Nutraceuticals

Milestones:

Floated as a Pvt. Ltd Company in 1989
Entered International Market in 1994
Became Public Ltd company in 1995
Issued an IPO in 1996
Listing in Bombay Stock Exchange in 1997
International market expansion via Product Registration Year 2000
Started APIs manufacturing in 2001
Strengthening of bottom line by trimming down less profitable products & markets in 2002
Expansions initiated in Regulated Markets

Achievements/ recognition :